151 related articles for article (PubMed ID: 25966467)
41. Live fluorescent RNA-based detection of pluripotency gene expression in embryonic and induced pluripotent stem cells of different species.
Lahm H; Doppler S; Dreßen M; Werner A; Adamczyk K; Schrambke D; Brade T; Laugwitz KL; Deutsch MA; Schiemann M; Lange R; Moretti A; Krane M
Stem Cells; 2015 Feb; 33(2):392-402. PubMed ID: 25335772
[TBL] [Abstract][Full Text] [Related]
42. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
43. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
Lampen A; Göttlicher M; Nau H
ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
[TBL] [Abstract][Full Text] [Related]
44. Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.
Yang Y; Adachi K; Sheridan MA; Alexenko AP; Schust DJ; Schulz LC; Ezashi T; Roberts RM
Proc Natl Acad Sci U S A; 2015 May; 112(18):E2337-46. PubMed ID: 25870291
[TBL] [Abstract][Full Text] [Related]
45. Modulation of integrin and E-cadherin-mediated adhesions to spatially control heterogeneity in human pluripotent stem cell differentiation.
Toh YC; Xing J; Yu H
Biomaterials; 2015 May; 50():87-97. PubMed ID: 25736499
[TBL] [Abstract][Full Text] [Related]
46. Efficient differentiation of human embryonic and induced pluripotent stem cells into functional astrocytes.
Emdad L; D'Souza SL; Kothari HP; Qadeer ZA; Germano IM
Stem Cells Dev; 2012 Feb; 21(3):404-10. PubMed ID: 21631388
[TBL] [Abstract][Full Text] [Related]
47. Chromosome microduplication in somatic cells decreases the genetic stability of human reprogrammed somatic cells and results in pluripotent stem cells.
Yu Y; Chang L; Zhao H; Li R; Fan Y; Qiao J
Sci Rep; 2015 May; 5():10114. PubMed ID: 25965553
[TBL] [Abstract][Full Text] [Related]
48. Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation.
Alisson-Silva F; de Carvalho Rodrigues D; Vairo L; Asensi KD; Vasconcelos-dos-Santos A; Mantuano NR; Dias WB; Rondinelli E; Goldenberg RC; Urmenyi TP; Todeschini AR
Glycobiology; 2014 May; 24(5):458-68. PubMed ID: 24578376
[TBL] [Abstract][Full Text] [Related]
49. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells.
Kao CL; Tai LK; Chiou SH; Chen YJ; Lee KH; Chou SJ; Chang YL; Chang CM; Chen SJ; Ku HH; Li HY
Stem Cells Dev; 2010 Feb; 19(2):247-58. PubMed ID: 19656070
[TBL] [Abstract][Full Text] [Related]
50. Human testis-derived embryonic stem cell-like cells are not pluripotent, but possess potential of mesenchymal progenitors.
Chikhovskaya JV; Jonker MJ; Meissner A; Breit TM; Repping S; van Pelt AM
Hum Reprod; 2012 Jan; 27(1):210-21. PubMed ID: 22095788
[TBL] [Abstract][Full Text] [Related]
51. Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells.
Maynard KM; Arvindam U; Cross M; Firpo MT
Exp Biol Med (Maywood); 2014 Apr; 239(4):484-8. PubMed ID: 24595983
[TBL] [Abstract][Full Text] [Related]
52. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
Puri MC; Nagy A
Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
[TBL] [Abstract][Full Text] [Related]
53. Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents.
Braun AG; Buckner CA; Emerson DJ; Nichinson BB
Proc Natl Acad Sci U S A; 1982 Mar; 79(6):2056-60. PubMed ID: 6952253
[TBL] [Abstract][Full Text] [Related]
54. In vitro micromass teratogen test: Interpretation of results from a blind trial of 25 compounds using three separate criteria.
Parsons JF; Rockley J; Richold M
Toxicol In Vitro; 1990; 4(4-5):609-11. PubMed ID: 20702239
[TBL] [Abstract][Full Text] [Related]
55. Structural disorder of monomeric α-synuclein persists in mammalian cells.
Theillet FX; Binolfi A; Bekei B; Martorana A; Rose HM; Stuiver M; Verzini S; Lorenz D; van Rossum M; Goldfarb D; Selenko P
Nature; 2016 Feb; 530(7588):45-50. PubMed ID: 26808899
[TBL] [Abstract][Full Text] [Related]
56. Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia.
Ejlerskov P; Hultberg JG; Wang J; Carlsson R; Ambjørn M; Kuss M; Liu Y; Porcu G; Kolkova K; Friis Rundsten C; Ruscher K; Pakkenberg B; Goldmann T; Loreth D; Prinz M; Rubinsztein DC; Issazadeh-Navikas S
Cell; 2015 Oct; 163(2):324-39. PubMed ID: 26451483
[TBL] [Abstract][Full Text] [Related]
57. Thalidomide-induced teratogenesis: history and mechanisms.
Vargesson N
Birth Defects Res C Embryo Today; 2015 Jun; 105(2):140-56. PubMed ID: 26043938
[TBL] [Abstract][Full Text] [Related]
58. Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.
Kowalski TW; Sanseverino MT; Schuler-Faccini L; Vianna FS
Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):794-803. PubMed ID: 26043318
[TBL] [Abstract][Full Text] [Related]
59. Presenilin-1 Dependent Neurogenesis Regulates Hippocampal Learning and Memory.
Bonds JA; Kuttner-Hirshler Y; Bartolotti N; Tobin MK; Pizzi M; Marr R; Lazarov O
PLoS One; 2015; 10(6):e0131266. PubMed ID: 26098332
[TBL] [Abstract][Full Text] [Related]
60. Anti-inflammatory effect of thalidomide dithiocarbamate and dithioate analogs.
Talaat R; El-Sayed W; Agwa HS; Gamal-Eldeen AM; Moawia S; Zahran MA
Chem Biol Interact; 2015 Aug; 238():74-81. PubMed ID: 26051520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
